Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Inari Medical (Standalone through FY2024Q3) by Year
Inari Medical (Standalone through FY2024Q3) — Research & Development Expense ($M) ($M)
Stryker Inari Medical (Standalone through FY2024Q3): $87.5M in FY2023, up 17.9% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2023
87.5
Period ended Dec 31, 2023
Change on a year earlier
+17.9%
74.2 in FY2022
History
6 years
Since FY2018
Sources
4
Documents cited below
Where the FY2023 figure comes from
Source: Inari Medical (NARI) 10K — FY2023 (filed 2024-02-29) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inari Medical (Standalone through FY2024Q3) — Research & Development Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 87.5 | +17.9% | Inari Medical (NARI) 10K — FY2023 (filed 2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 74.2 | +45.5% | Inari Medical (NARI) 10K — FY2023 (filed 2024-02-29) ↗ |
| FY2021 | Dec 31, 2021 | 51.0 | +177.3% | Inari Medical (NARI) 10K — FY2023 (filed 2024-02-29) ↗ |
| FY2020 | Dec 31, 2020 | 18.4 | +154.8% | Inari Medical (NARI) 10K — FY2022 (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 7.22 | +81.0% | Inari Medical (NARI) 10K — FY2021 (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 3.99 | – | Inari Medical (NARI) 10K — FY2020 (filed 2021-03-09) ↗ |
Cite this data
StockData. (2026). Stryker Inari Medical (Standalone through FY2024Q3) ($M), annual FY2018–FY2023 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-rd
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.